Studies with functional nonlymphoid thymomas showed that when the tumors were grafted into neonatally thymectomized aUogeneic hosts, immunological restoration was mediated by the host's own lymphoid cells (1). Comparable results had been previously reported with thymus grafts (2-6), while spleen cells produced adoptive restoration mediated by donor cells (4, 7). It was suggested that the tumoral nonlymphoid stroma of the thymus may act in an indirect way inducing differentiation and/or expansion of a population of potentially competent ceils in the lymphoid tissues of thymectomized hosts (1). This hypothesis was supported by evidence of the functional capacity of the thymomas when enclosed in cell-impenetrable diffusion chambers (8).
Studies with functional nonlymphoid thymomas showed that when the tumors were grafted into neonatally thymectomized aUogeneic hosts, immunological restoration was mediated by the host's own lymphoid cells (1) . Comparable results had been previously reported with thymus grafts (2-6), while spleen cells produced adoptive restoration mediated by donor cells (4, 7) . It was suggested that the tumoral nonlymphoid stroma of the thymus may act in an indirect way inducing differentiation and/or expansion of a population of potentially competent ceils in the lymphoid tissues of thymectomized hosts (1) . This hypothesis was supported by evidence of the functional capacity of the thymomas when enclosed in cell-impenetrable diffusion chambers (8) .
In a preliminary report (9) , we observed a decrease of the restorative capacity of a functional thymoma in neonatally thymectomized conventional mice when the treatment was delayed after thymectomy. Treatment became ineffective when performed at 50 days of age or later. These results suggested that a population of cells in the tissues of the thymectomized hosts, capable of responding to the inductive or expanding action of the thymoma, decreased progressively with time after neonatal thymectomy in the absence of thymic function. Our present results also indicate that with delay of the treatment a similar decrease in restoring capacity was observed when thymus grafts, thymus in diffusion chambers, and thymomas alone or in diffusion chambers were used.
Materials and Methods
Animals.--Inbred mice of the A, C3Hf/Bi, DBA/2, and C57BL/1 strains were used. Strain details and animal care were described in a previous paper (1) .
Tecknlcal Procedures.--The techniques for neonatal thymectomy, thymoma and thymus * Aided by Public Health Service research grant CA-10445 from the National Cancer Institute; by grant AI 00798 from the National Institute of Allergy and Infectious Disease; by the National Foundation--March of Dimes; and by the Minnesota Heart Association and the University of Minnesota Graduate School. 8O9 (Table VII) ; (iv) wasted C3HI/Bi mice treated with: subcutaneous grafts of A thymoma or A sarcoma; intraperitoneal injection of 200 or 400 X 10 6 spleen cells from 5-day old or 45-day old neonatally thymectomized C3Hf/Bi mice; and a combination of subcutaneous tumors and intraperitoneal spleen cells (Table VIII) .
RESULTS
Effect of Age at Treatment.-- Table I shows the influence of delaying treatment after neonatal thymectomy in strain A mice on the restorative capacity of syngeneic functional thymoma and thymus grafted subcutaneously. A progressive aUogeneic thymus or thymoma grafts takes place when the treatment is delayed after neonatal thymectomy. When syngeneic or allogeneic thymus grafts were implanted intraperitoneally in neonatally thymectomized C3Hf/Bi mice, comparable decrease in effectiveness was observed (Table III) .
When syngeneic or allogeneic thymus grafts or functional thymomas were grafted intraperitoneaUy within cell-impenetrable diffusion chambers in neonatally thymectomized C3Hf/Bi mice, a marked decrease in effectivity was observed when the treatment was performed after 25 days of age (Table IV) . When treatment was performed at 10-20 days, restoration was observed in 40% (17/ 42) mice treated with syngeneic C3Hf/Bi thymus, 39% (17/43) treated with allogeneic A thymus, 65 % (39/60) grafted with syngeneic C3H/Bi thymoma, and 56 % (24/43) animals grafted with allogeneic strain A thymoma. When the Table V shows that when grafted subcutaneously or intraperitoneally, five thymuses of syngeneic origin and to less degree of allogeneic strains can reverse the wasting syndrome after its onset. One thymus graft is usually ineffective. Thymoma grafts in syngeneic or allogeneic host mice with wasting disease were ineffective (Table V) . Table VI shows that one thymus, multiple thymuses or, functional thymomas of syngeneic or allogeneic origin enclosed in cell-impenetrable diffusion chambers are incapable of reversing the postthymectomy wasting after its onset. All animals died 5-45 days after the treatment was performed and showed no restoration of immunological responses. Table VII shows that wasted A mice could be restored only with intraperitoneal spleen cells from 5-day old neonatally thymectomized syngeneic donors in combination with subcutaneous grafts of the strain A functional thymoma. Spleen cells from 45-day old neonatally thymectomized donors were ineffective. Table VIII shows similar experiments performed in wasted C3Hf/Bi mice. As in the previous experiments, spleen cells from 5-day old neonatally thymectomized syngeneic donors injected intraperitoneally were effective in reversing the wasting when associated with subcutaneous grafts of the functional strain A thymoma. Spleen cells from 45-day old neonatally thymectomized donors in association with thymoma grafts were ineffective. In both types of experiments thymoma grafts alone, spleen cells, or spleen cells in association with a nonfunctional strain A sarcoma were ineffective in reversing the wasting syndrome after its onset. Further, they were unable to induce restoration of any of the parameters studied.
Effect of Spleen Cells from Thymectomized Donors.--

DISCUSSION
Restoration of neonataUy thymectomized mice with thymus grafts suggested that the thymus is acting in an indirect way, since all the immunocompetent cells are derived from the host (2-6). Comparable results were obtained with functional thymomas (1), or thymus, or thymomas within cell-impenetrable diffusion chambers. 1 The cell-impenetrable chamber experiments suggested that the thymus may act by means of a humoral diffusible factor (10) . Other mechanisms of thymic function include a traffic through thymic stroma of cells of hemopoietic origin (11) and a seeding out of a thymus-derived cell population to the peripheral lymphoid tissue (12) . The three possible mechanisms of thymic action are not mutually exclusive, although the quantitative contribution of each component under physiological conditions is unknown. It would seem from our present results that two factors are necessary for normal development and continued function of the thymus: an intact reticuloepithelial framework, related to the inductive function; and a supply of "stem" cells, probably of hemopoietic origin, sensitive to the inductive action of the thymus.
Our present results can be summarized as follows: (a) there is a progressive decrease of restorative effectiveness of thymoma or thymus grafts when the treatment of neonatally thymectomized mice is delayed; (b) early restoration between 5 and 20 days after thymectomy is effective, while the number of restored animals is markedly decreased following attempts to achieve restoration between 30 and 50 days postthymectomy; (c) comparable results are obtained with subcutaneous grafts, intraperitoneal grafts, or grafts within cell-impenetrable diffusion chambers (Tables I-IV) . It is possible that the population of cells capable of responding to the inductive action of the thymoma or thymus in diffusion chambers may represent a population that received "thymic influence" before thymectomy was performed, and that the humoral function of the thymus can expand solely such population of "postthymic" cells in the peripheral tissues of the host (13) . In mice reared in conventional environment, the decay of the postthymic cells with time may be partly explained by an exhaustion due to lack of replacement in absence of thymic function and/or through commitment to immunological functions.
A decrease in effectiveness, although less marked, was observed when syngeneic thymus grafts were used (Table I-III), indicating that the difference may be due to the thymic stroma itself. It can be theorized that the population of "postthymic" cells arises through a traffic of bone marrow cells to the thymus, and that only normal syngeneic thymus (as opposed to allogeneic thymus, thymomas, or thymus in diffusion chambers) can provide optimal conditions for traffic of cells of hemopoietic origin and for the building up of a population of "postthymic" cells capable of response to the inductive or expanding humoral activity of the thymus (13) . The comparison between spleen cells from 5-day old and 45-day old neonatally thymectomized mice for their capacity to reverse the postthymectomy-wasting syndrome when given in association with thymoma grafts also indicates that a population of cells sensitive to the function of the thymoma is present in the spleen cells of 5-day old thymectomized mice and is absent in the spleen cells from 45-day old neonatally thymectomized hosts (Tables VII and VIII ). All these results are compatible with the view that a special cell is present in the peripheral tissues of the neonatally thymtecomized host. This special cell is sensitive to the inductive or expanding action of the thymus. This intermediate cell requires the presence of the thymus for renewal of its population and will decrease progressively in absence of thymic function. Additional experiments (13) indicate that this type of cell is already present in lymphohemopoietic tissues of newborn mice but is absent in the hemopoietic tissues of embryonic mice. The difference between the "embryonic" and "newborn" type of cell is that the latter is sensitive to the humoral action of the thymus (thymoma or thymus in diffusion chambers), while the former needs the normal thymic stroma to achieve the state of immunological competence. This suggests that thymus traffic must occur for this influence to be exercised (13) .
The effect of allogeneic thymus grafts (Tables II and III) is comparable to previous experiments, suggesting that differences in influence between allogeneic and syngeneic or F1 hybrid parent combinations may be attributed to a graftversus-host reaction (4) (5) (6) 14) .
The experiments on reversal of the postthymectomy-wasting syndrome deserve comment. Wasting in thymectomized mice can be prevented or delayed under germfree conditions, suggesting that environmental factors influence the pathogenesis of this syndrome (15) . However, the wasting model is still of importance since it mimics dramatically the syndrome observed in the human lymphopenic states (16, 17) . In previous publications we showed that the postthymectomy syndrome could be easily reversed adoptively with immunocompetent cells, and that multiple thymus grafts could also effectively reverse the syndrome and restore such animals to health and immunologic competence (4, 5, 7) . Thymus grafts showed that restoration was eventually mediated by the host's own lymphoid cells (5) . The present results confirm previous finding (5, 18) , showing that the only effective treatment with thymus grafts of the postthymectomy wasting after its onset was the implantation of multiple thymus grafts (Table V) . On the other hand, Table VI shows that when only the humoral activity of the thymus was employed (multiple thymuses or thymoma in diffusion chambers), no reversal of the wasting syndrome was observed. These results suggest that an initial "cellular" stage is needed for the reversal of the syndrome. This cellular stage could be represented by a component of thymusderived cells (12) and/or by traific of host cells through the thymus grafts (11) . The quantitative difference between multiple and single thymus grafts may be due to the acuteness of the disease and the marked decrease of "postthymic" cells with time after thymectomy. This difference is indicated in experiments reported here. One article in which postthymectomy wasting was reversed with multiple thymus grafts within diffusion chambers in 35 % of the treated animals has been presented (19) . Timing of the treatment, strain variations, environmental factors, restoration criteria, and techniques used for construction of the chambers (0.30 as opposed to 0.22 # mean pore size filters) could easily account for the difference in results. The two last points may be important since (a) our restoration criteria, besides survival, include the return to normal of two immunological parameters in the same animal; and (b) our report states that the 0.30/z mean pore size permits some cell traffic across the filters (8) .
SU~r~Ry
A progressive decrease of the restoring effectivity of syngeneic or allogeneic thymus and functional thymoma grafts was observed when the treatment of neonatally thymectomized mice was delayed. Early treatment (5-20 days postthymectomy) was effective, while the number of restored animals was markedly decreased after late treatment (30-50 days postthymectomy). Similar results were obtained with subcutaneous or intraperitoneal thymus grafts and with thymus grafts within cell-impenetrable diffusion chambers. After the onset of the postthymectomy-wasting syndrome the only successful treatment was the implantation of multiple thymus grafts. On the other hand, single thymus grafts, thymoma grafts, or thymus or thymoma within diffusion chambers were ineffective. When spleen cells from 5-day old or 45-day old neonatally thymec-~.omized animals were given in association with thymoma grafts, only the cells derived from the 5-day old thymectomized mice proved effective in restoring wasted thymectomized hosts. These results suggest that a population of cells sensitive to the action of the thymus decreases progressively with time in the absence of thymic function.
